NOT-DA-21-080: Notice of Correction to the Key Date Section in PAR-21-320, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"

Notice of Correction to the Key Date Section in PAR-21-320, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"

Notice Number:

NOT-DA-21-080

Key Dates

Release Date:

September 10, 2021

Related Announcements

PAR-21-320 - NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)

Issued by

National Institute on Drug Abuse (NIDA)

Purpose

The purpose of this Notice is to alert potential applicants to a change in Key Dates and Application Types Allowed in, PAR-21-320, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)"

The following sections of PAR-21-320, "NIDA Research Education Program for Clinical Researchers and Clinicians (R25 Clinical Trial Not Allowed)".

Currently Reads:

Part 1. Key Dates

Section II. Award Information

Key Dates

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS	Scientific Merit Review	Advisory Council Review	Earliest Start Date
November 15, 2021	November 15, 2021	November 15, 2021	February 2022	January 2022	April 2022
March 15, 2022	March 15, 2022	March 15, 2022	June 2022	May 2022	July 2022
August 10, 2022	August 10, 2022	August 10, 2022	November 2022	October 2022	December 2022
November 15, 2022	November 15, 2022	November 15, 2022	February 2023	January 2023	April 2023
March 15, 2023	March 15, 2023	March 15, 2023	June 2023	May 2023	July 2023
August 10, 2023	August 10, 2023	August 10, 2023	November 2023	October 2023	December 2023
November 15, 2023	November 15, 2023	November 15, 2023	February 2024	January 2024	April 2024
March 15, 2024	March 15, 2024	March 15, 2024	June 2024	May 2024	July 2024
August 09, 2024	August 09, 2024	August 09, 2024	November 2024	October 2024	December 2024

Correct Dates: (shown in bold italic)

Part 1. Key Dates

Section II. Award Information

Key Dates

Application Due Dates			Review and Award Cycles
New	Renewal / Resubmission / Revision (as allowed)	AIDS	Scientific Merit Review	Advisory Council Review	Earliest Start Date
November 15, 2021	November 15, 2021	November 15, 2021	February 2022	May 2022	July 2022
March 15, 2022	March 15, 2022	March 15, 2022	June 2022	October 2022	December 2022
August 10, 2022	August 10, 2022	August 10, 2022	November 2022	January 2023	April 2023
November 15, 2022	November 15, 2022	November 15, 2022	February 2023	May 2023	July 2023
March 15, 2023	March 15, 2023	March 15, 2023	June 2023	October 2023	December 2023
August 10, 2023	August 10, 2023	August 10, 2023	November 2023	January 2024	April 2024
November 15, 2023	November 15, 2023	November 15, 2023	February 2024	May 2024	July 2024
March 15, 2024	March 15, 2024	March 15, 2024	June 2024	October 2024	December 2024
August 09, 2024	August 09, 2024	August 09, 2024	November 2024	January 2025	April 2025

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Aria Davis Crump, Sc.D.
Division of Epidemiology, Services and Prevention Research
National Institute on Drug Abuse (NIDA)
Telephone:301-435-0881
Email: [email protected]

Guifang Lao, Ph.D.
Division of Therapeutics and Medical Consequences
National Institute on Drug Abuse (NIDA)
Telephone: 301-443-6173
Email: [email protected]

Yu (Woody) Lin, M.D., Ph.D.
Integrative Neuroscience Branch
Division of Neuroscience and Behavioral Research
National Institute on Drug Abuse (NIDA)
Telephone: 301 435-1318
Email: [email protected]

Beth Babecki, M.A.
Coordinator, Training Hub
Division of Neuroscience and Behavioral Research
National Institute on Drug Abuse (NIDA)
Telephone: 301-435-0899
Email: [email protected]